The U.S. Black population is 12.4%, and at ChristianaCare, 32% of the heart failure patient population is Black — a race that has historically experienced healthcare disparities for heart failure treatment, including low adherence to guideline-directed medical therapy.
To counteract rates of substandard care, ChristianaCare locked arms with health technology company Story Health, the Newark, Del.-based system said in a Feb. 23 news release.
With Story Health, the system launched a digital platform that offers a health coach who helps with medication adherence, coordinates lab work and aids patients with transportation and prescription assistance.
Here are the collaboration’s results:
- Six times improvement on target doses of beta blockers (76%)
- Seven times improvement on target doses of angiotensin converting enzyme inhibitors, angiotensin receptor blockers and angiotensin receptor neprilysin inhibitors (54%)
- Two times improvement on target doses of mineralocorticoid receptor antagonists (57%)
- Increase in sodium-glucose cotransporter 2 inhibitor adherence, rising from a 32% baseline to 74%
- Decrease in average absolute systolic and diastolic blood pressure levels after 120 days
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
